Reproductive endocrinology.
The theme running through the articles in this issue on reproductive medicine is that of the safety of the medical treatments we use in this specialty. Two of the articles focus on familiar medications, such as the oral contraceptive pill and the drugs used to induce ovulation, and two focus on the benefits and potential hazards of new approaches to treatment, viz the reduction of insulin drive in women with polycystic ovary syndrome and the use of selective modulators of estrogen receptors in postmenopausal women with osteoporosis.